We detected four mutations (p.R273S in AML-MR; p.C275Y and p.N239D in AML-MR and MDS-LB; p.R248Q in MDS-IB patients, respectively) of such residues, which directly contribute to the interaction of p53 with DNA. This evidence concerns the gene TP53 and acute myeloid leukemia.